- Q1 2024 FibroGen Inc Earnings Call TranscriptMay 06, 2024MXN20.25 (-6.98%)Earnings
- Q4 2023 FibroGen Inc Earnings Call TranscriptFeb 26, 2024MXN30 (-20.09%)Earnings
- FibroGen Inc KOL Investor Event Series Part I (Virtual) TranscriptFeb 13, 2024
- Q3 2023 FibroGen Inc Earnings Call TranscriptNov 06, 2023MXN15.08Earnings
- Q2 2023 FibroGen Inc Earnings Call TranscriptAug 07, 2023MXN31 (-90.91%)Earnings
- FibroGen Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- FibroGen Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 FibroGen Inc Earnings Call TranscriptMay 08, 2023MXN341.2Earnings
- Q4 2022 FibroGen Inc Earnings Call TranscriptFeb 27, 2023MXN461.5Earnings
- FibroGen Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Q3 2022 FibroGen Inc Earnings Call TranscriptNov 07, 2022MXN350.5Earnings
- Q2 2022 FibroGen Inc Earnings Call TranscriptAug 08, 2022MXN251Earnings
- Q1 2022 FibroGen Inc Earnings Call TranscriptMay 09, 2022MXN257.5Earnings
- Q4 2021 FibroGen Inc Earnings Call TranscriptFeb 28, 2022MXN314Earnings
- Q3 2021 FibroGen Inc Earnings Call TranscriptNov 09, 2021MXN246 (-8.21%)Earnings
- Q2 2021 FibroGen Inc Earnings Call TranscriptAug 09, 2021MXN278 (+0.36%)Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- FibroGen Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2021
- FibroGen Inc Annual Shareholders Meeting TranscriptMay 26, 2021
- FibroGen Inc at Bank of America Global Research Healthcare Conference (Virtual) - Fireside Chat TranscriptMay 13, 2021
- Q1 2021 FibroGen Inc Earnings Call TranscriptMay 10, 2021MXN386.14 (-6.25%)Earnings
- FibroGen Inc Provides Additional Information on Roxadustat - Conference Call TranscriptApr 06, 2021
- FibroGen Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 FibroGen Inc Earnings Call TranscriptMar 01, 2021MXN1037Earnings
- FibroGen Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- FibroGen Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- Q3 2020 FibroGen Inc Earnings Call TranscriptNov 05, 2020MXN1012Earnings
- FibroGen Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- FibroGen Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Q2 2020 FibroGen Inc Earnings Call TranscriptAug 06, 2020MXN987Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- FibroGen Inc Annual Shareholders Meeting TranscriptJun 04, 2020
- FibroGen Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- FibroGen Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 FibroGen Inc Earnings Call TranscriptMay 07, 2020MXN900Earnings
- Q4 2019 FibroGen Inc Earnings Call TranscriptMar 02, 2020MXN800 (-2.91%)Earnings
- FibroGen Inc at Leerink Global Healthcare Conference TranscriptFeb 25, 2020
- Q3 2019 FibroGen Inc Earnings Call TranscriptNov 11, 2019MXN645Earnings
- Q2 2019 FibroGen Inc Earnings Call TranscriptAug 08, 2019MXN740Earnings
- FibroGen Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Q1 2019 FibroGen Inc Earnings Call TranscriptMay 09, 2019MXN890Earnings
- Q4 2018 FibroGen Inc Earnings Call TranscriptFeb 27, 2019MXN865Earnings
FibroGen Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Okay. Welcome back, everyone, and thank you for joining us on Day 3 of the 42nd Annual Goldman Sachs Global Healthcare Conference. I'm Paul Choi, and I cover the mid-cap biotechnology sector here at the firm. And our next session will be with FibroGen.
Joining us from management is CEO, Enrique Conterno. What we'll do as in prior sessions is we'll turn it over to Enrique for some opening commentary, and then we'll go into Q&A. (Operator Instructions)
But otherwise, with that, we'll turn it over to Enrique.
Thank you, Paul, and thank you for the invitation. A few comments on FibroGen. We are, of course, excited about the -- having the AdCom with the -- here in the U.S., and the preparations are going well. The AdCom is July 15. Also waiting for the regulatory decision in Europe. That's another important milestone for us.
And of course, I think, continue to be very bullish about our performance in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)